tiprankstipranks
Commercialization through large partner among Anixa goals, CEO tells The Fly
PremiumThe FlyCommercialization through large partner among Anixa goals, CEO tells The Fly
3M ago
Anixa could begin human testing for ovarian cancer vaccine by 2025, CEO says
PremiumThe Fly
Anixa could begin human testing for ovarian cancer vaccine by 2025, CEO says
3M ago
Anixa CEO says breast cancer vaccine data looking ‘incredibly promising’
PremiumThe Fly
Anixa CEO says breast cancer vaccine data looking ‘incredibly promising’
3M ago
Anixa Biosciences granted additional U.S. patent for ovarian cancer vaccine tech
PremiumThe FlyAnixa Biosciences granted additional U.S. patent for ovarian cancer vaccine tech
7M ago
Anixa Biosciences announces treatment of third patient in CAR-T trial
PremiumThe Fly
Anixa Biosciences announces treatment of third patient in CAR-T trial
8M ago
Anixa Biosciences announces enrollment for Keytruda treatment arm
PremiumThe Fly
Anixa Biosciences announces enrollment for Keytruda treatment arm
8M ago
Anixa Biosciences price target raised to $12 from $11 at H.C. Wainwright
PremiumThe FlyAnixa Biosciences price target raised to $12 from $11 at H.C. Wainwright
1y ago
Anixa Biosciences reassures shareholders it has no accounts at SVB
PremiumThe Fly
Anixa Biosciences reassures shareholders it has no accounts at SVB
1y ago
Anixa Biosciences issued NoA from USPTO for breast cancer vaccine technology
PremiumThe Fly
Anixa Biosciences issued NoA from USPTO for breast cancer vaccine technology
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100